Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
278.17
+5.26 (1.93%)
Jan 29, 2026, 12:54 PM EST - Market open
Krystal Biotech Employees
Krystal Biotech had 275 employees as of December 31, 2024. The number of employees increased by 46 or 20.09% compared to the previous year.
Employees
275
Change (1Y)
46
Growth (1Y)
20.09%
Revenue / Employee
$1,356,960
Profits / Employee
$723,309
Market Cap
8.07B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 275 | 46 | 20.09% | 275 | 0 |
| Dec 31, 2023 | 229 | 19 | 9.05% | 229 | 0 |
| Dec 31, 2022 | 210 | 91 | 76.47% | 210 | 0 |
| Dec 31, 2021 | 119 | 44 | 58.67% | 119 | 0 |
| Dec 31, 2020 | 75 | 22 | 41.51% | 75 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Jazz Pharmaceuticals | 2,800 |
| Caris Life Sciences | 1,769 |
| Axsome Therapeutics | 816 |
| Arrowhead Pharmaceuticals | 711 |
| Cytokinetics | 498 |
| Vaxcyte | 414 |
| Halozyme Therapeutics | 350 |
| Rhythm Pharmaceuticals | 283 |
KRYS News
- 13 days ago - Krystal Biotech: Beyond VYJUVEK Commercialization - Seeking Alpha
- 14 days ago - These under-the-radar stocks combine fast growth with big upside potential - Market Watch
- 17 days ago - Krystal Biotech, Inc. (KRYS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 20 days ago - Krystal Biotech, Inc. (KRYS) Discusses Positive Interim Results and Next Steps for Cystic Fibrosis Program KB407 Transcript - Seeking Alpha
- 2 months ago - Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 2 months ago - Krystal Biotech: Vyjuvek Gene Therapy Well Positioned For Growth - Seeking Alpha
- 3 months ago - Krystal's Q3: Platform Designation Adds Pipeline Leverage As Vyjuvek Scales (Rating Upgrade) - Seeking Alpha